Offer - Urjas Oil for just ₹ 1 X
Sevlaren 800 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Increased Phosphate Levels in the Blood. Secondary and off-label uses of Sevlaren 800 Tablet have also been mentioned below.
The correct dosage of Sevlaren 800 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Sevlaren 800 Tablet have been listed ahead. These side effects of Sevlaren 800 Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Sevlaren 800 Tablet has a Unknown effect for pregnant women and Safe effect on lactating mothers. Warnings related to Sevlaren 800 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Sevlaren 800 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Intestinal Obstruction are examples of such conditions. Other contraindications of Sevlaren 800 Tablet have been discussed in the sections ahead.
Drug reaction of Sevlaren 800 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Sevlaren 800 Tablet is considered safe while driving, and is addictive.
Sevlaren 800 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Is the use of Sevlaren 800 Tablet safe for pregnant women?
The effects of Sevlaren on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Sevlaren 800 Tablet safe during breastfeeding?
Breastfeeding women can safely use Sevlaren.
What is the effect of Sevlaren 800 Tablet on the Kidneys?
Sevlaren rarely harms the kidneys.
What is the effect of Sevlaren 800 Tablet on the Liver?
So far, no research has been carried out on the effects of Sevlaren on the liver. So it is not known whether taking Sevlaren will affect the liver or not.
What is the effect of Sevlaren 800 Tablet on the Heart?
No research work has been carried out till date on effects of Sevlaren on heart. So it is not known whether taking Sevlaren will cause side effects on heart or not.
If you are suffering from any of the following diseases, you should not take Sevlaren 800 Tablet unless your doctor advises you to do so -
Is this Sevlaren 800 Tablet habit forming or addictive?
No, you will not get addicted to Sevlaren 800 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Sevlaren 800 Tablet since it does not cause drowsiness.
Is it safe?
Sevlaren 800 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Sevlaren 800 Tablet for mental disorders.
Interaction between Food and Sevlaren 800 Tablet
Information is not available on the interaction of any foods with Sevlaren 800 Tablet, due to a lack of research on this.
Interaction between Alcohol and Sevlaren 800 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Sevlaren 800 Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Renvela (sevelamer carbonate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1134-1135